The emergence of COVID-19 has substantially disrupted delivery of cancer care, with postponements and cancellations of surgeries, as well as delays in systemic and radiotherapies. For patients with slow-growing tumors, these delays may be safe, but for others, waiting to start treatment can have a negative impact on outcomes. The benefits and risks of immediate […]
Read more